(NOV) NOV - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US62955J1034
Drilling Equipment, Rig Components, Downhole Tools, Pressure Pumping, Production
Dividends
| Dividend Yield | 3.13% |
| Yield on Cost 5y | 3.93% |
| Yield CAGR 5y | 53.14% |
| Payout Consistency | 82.5% |
| Payout Ratio | 43.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 37.7% |
| Value at Risk 5%th | 55.7% |
| Relative Tail Risk | -10.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | -14.12 |
| CAGR/Max DD | -0.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.480 |
| Beta | 1.342 |
| Beta Downside | 1.794 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.70% |
| Mean DD | 29.41% |
| Median DD | 29.88% |
Description: NOV NOV November 05, 2025
NOV Inc. (NYSE: NOV) designs, manufactures and sells a broad portfolio of equipment and services for oil- and-gas drilling, production, and related industrial and renewable-energy markets. The firm operates through two segments-Energy Equipment and Energy Products & Services-covering everything from solids-control and waste-management gear to hydraulic-fracturing pumps, coiled-tubing units, artificial-lift systems, offshore production technology, and wind-turbine installation equipment.
In FY 2023 the company generated roughly $13.5 billion in revenue, with the Energy Equipment segment contributing about 65 % of sales. Its order backlog stood near $10 billion, indicating near-term demand resilience despite cyclical oil-price pressure. Key economic drivers include global rig count trends (which moved +12 % YoY in Q3 2024), oil-price volatility (a 15 % swing in Brent since early 2024), and the growing share of renewable-energy projects that boost demand for wind-turbine installation cranes and offshore subsea solutions.
To evaluate NOV’s valuation and risk profile in more depth, you might explore the detailed metrics and scenario analyses available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (383.0m TTM) > 0 and > 6% of Revenue (6% = 526.1m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 0.90pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 39.89% (prev 40.66%; Δ -0.77pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 1.27b > Net Income 383.0m (YES >=105%, WARN >=100%) |
| Net Debt (1.15b) to EBITDA (953.0m) ratio: 1.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.55 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (371.0m) change vs 12m ago -6.08% (target <= -2.0% for YES) |
| Gross Margin 22.03% (prev 24.05%; Δ -2.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 77.06% (prev 77.91%; Δ -0.85pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.64 (EBITDA TTM 953.0m / Interest Expense TTM 90.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.78
| (A) 0.31 = (Total Current Assets 5.76b - Total Current Liabilities 2.26b) / Total Assets 11.34b |
| (B) -0.05 = Retained Earnings (Balance) -568.0m / Total Assets 11.34b |
| (C) 0.05 = EBIT TTM 598.0m / Avg Total Assets 11.38b |
| (D) -0.41 = Book Value of Equity -1.97b / Total Liabilities 4.83b |
| Total Rating: 1.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.31
| 1. Piotroski 5.50pt |
| 2. FCF Yield 12.75% |
| 3. FCF Margin 10.00% |
| 4. Debt/Equity 0.36 |
| 5. Debt/Ebitda 1.20 |
| 6. ROIC - WACC (= -3.52)% |
| 7. RoE 5.94% |
| 8. Rev. Trend 79.50% |
| 9. EPS Trend 47.28% |
What is the price of NOV shares?
As of December 05, 2025, the stock is trading at USD 16.30 with a total of 2,643,051 shares traded.
Over the past week, the price has changed by +6.12%, over one month by +10.51%, over three months by +22.70% and over the past year by +7.01%.
Over the past week, the price has changed by +6.12%, over one month by +10.51%, over three months by +22.70% and over the past year by +7.01%.
Is NOV a buy, sell or hold?
NOV has received a consensus analysts rating of 3.54.
Therefor, it is recommend to hold NOV.
- Strong Buy: 5
- Buy: 7
- Hold: 9
- Sell: 2
- Strong Sell: 1
What are the forecasts/targets for the NOV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.3 | 0.2% |
| Analysts Target Price | 16.3 | 0.2% |
| ValueRay Target Price | 17 | 4.5% |
NOV Fundamental Data Overview December 03, 2025
Market Cap USD = 5.73b (5.73b USD * 1.0 USD.USD)
P/E Trailing = 15.5859
P/E Forward = 13.3511
P/S = 0.653
P/B = 0.8679
P/EG = 0.2683
Beta = 0.977
Revenue TTM = 8.77b USD
EBIT TTM = 598.0m USD
EBITDA TTM = 953.0m USD
Long Term Debt = 1.69b USD (from longTermDebt, last quarter)
Short Term Debt = 135.0m USD (from shortTermDebt, last quarter)
Debt = 2.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.15b USD (from netDebt column, last quarter)
Enterprise Value = 6.88b USD (5.73b + Debt 2.35b - CCE 1.21b)
Interest Coverage Ratio = 6.64 (Ebit TTM 598.0m / Interest Expense TTM 90.0m)
FCF Yield = 12.75% (FCF TTM 877.0m / Enterprise Value 6.88b)
FCF Margin = 10.00% (FCF TTM 877.0m / Revenue TTM 8.77b)
Net Margin = 4.37% (Net Income TTM 383.0m / Revenue TTM 8.77b)
Gross Margin = 22.03% ((Revenue TTM 8.77b - Cost of Revenue TTM 6.84b) / Revenue TTM)
Gross Margin QoQ = 18.93% (prev 26.46%)
Tobins Q-Ratio = 0.61 (Enterprise Value 6.88b / Total Assets 11.34b)
Interest Expense / Debt = 0.93% (Interest Expense 22.0m / Debt 2.35b)
Taxrate = 39.73% (29.0m / 73.0m)
NOPAT = 360.4m (EBIT 598.0m * (1 - 39.73%))
Current Ratio = 2.55 (Total Current Assets 5.76b / Total Current Liabilities 2.26b)
Debt / Equity = 0.36 (Debt 2.35b / totalStockholderEquity, last quarter 6.46b)
Debt / EBITDA = 1.20 (Net Debt 1.15b / EBITDA 953.0m)
Debt / FCF = 1.31 (Net Debt 1.15b / FCF TTM 877.0m)
Total Stockholder Equity = 6.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.38% (Net Income 383.0m / Total Assets 11.34b)
RoE = 5.94% (Net Income TTM 383.0m / Total Stockholder Equity 6.44b)
RoCE = 7.35% (EBIT 598.0m / Capital Employed (Equity 6.44b + L.T.Debt 1.69b))
RoIC = 4.41% (NOPAT 360.4m / Invested Capital 8.18b)
WACC = 7.93% (E(5.73b)/V(8.09b) * Re(10.96%) + D(2.35b)/V(8.09b) * Rd(0.93%) * (1-Tc(0.40)))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.33%
[DCF Debug] Terminal Value 58.55% ; FCFE base≈838.6m ; Y1≈550.6m ; Y5≈251.8m
Fair Price DCF = 9.07 (DCF Value 3.31b / Shares Outstanding 364.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 47.28 | EPS CAGR: 72.15% | SUE: -1.44 | # QB: 0
Revenue Correlation: 79.50 | Revenue CAGR: 10.10% | SUE: 1.19 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.23 | Chg30d=+0.004 | Revisions Net=+2 | Analysts=8
EPS next Year (2026-12-31): EPS=1.12 | Chg30d=+0.024 | Revisions Net=+4 | Growth EPS=+21.5% | Growth Revenue=-0.4%
P/E Trailing = 15.5859
P/E Forward = 13.3511
P/S = 0.653
P/B = 0.8679
P/EG = 0.2683
Beta = 0.977
Revenue TTM = 8.77b USD
EBIT TTM = 598.0m USD
EBITDA TTM = 953.0m USD
Long Term Debt = 1.69b USD (from longTermDebt, last quarter)
Short Term Debt = 135.0m USD (from shortTermDebt, last quarter)
Debt = 2.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.15b USD (from netDebt column, last quarter)
Enterprise Value = 6.88b USD (5.73b + Debt 2.35b - CCE 1.21b)
Interest Coverage Ratio = 6.64 (Ebit TTM 598.0m / Interest Expense TTM 90.0m)
FCF Yield = 12.75% (FCF TTM 877.0m / Enterprise Value 6.88b)
FCF Margin = 10.00% (FCF TTM 877.0m / Revenue TTM 8.77b)
Net Margin = 4.37% (Net Income TTM 383.0m / Revenue TTM 8.77b)
Gross Margin = 22.03% ((Revenue TTM 8.77b - Cost of Revenue TTM 6.84b) / Revenue TTM)
Gross Margin QoQ = 18.93% (prev 26.46%)
Tobins Q-Ratio = 0.61 (Enterprise Value 6.88b / Total Assets 11.34b)
Interest Expense / Debt = 0.93% (Interest Expense 22.0m / Debt 2.35b)
Taxrate = 39.73% (29.0m / 73.0m)
NOPAT = 360.4m (EBIT 598.0m * (1 - 39.73%))
Current Ratio = 2.55 (Total Current Assets 5.76b / Total Current Liabilities 2.26b)
Debt / Equity = 0.36 (Debt 2.35b / totalStockholderEquity, last quarter 6.46b)
Debt / EBITDA = 1.20 (Net Debt 1.15b / EBITDA 953.0m)
Debt / FCF = 1.31 (Net Debt 1.15b / FCF TTM 877.0m)
Total Stockholder Equity = 6.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.38% (Net Income 383.0m / Total Assets 11.34b)
RoE = 5.94% (Net Income TTM 383.0m / Total Stockholder Equity 6.44b)
RoCE = 7.35% (EBIT 598.0m / Capital Employed (Equity 6.44b + L.T.Debt 1.69b))
RoIC = 4.41% (NOPAT 360.4m / Invested Capital 8.18b)
WACC = 7.93% (E(5.73b)/V(8.09b) * Re(10.96%) + D(2.35b)/V(8.09b) * Rd(0.93%) * (1-Tc(0.40)))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.33%
[DCF Debug] Terminal Value 58.55% ; FCFE base≈838.6m ; Y1≈550.6m ; Y5≈251.8m
Fair Price DCF = 9.07 (DCF Value 3.31b / Shares Outstanding 364.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 47.28 | EPS CAGR: 72.15% | SUE: -1.44 | # QB: 0
Revenue Correlation: 79.50 | Revenue CAGR: 10.10% | SUE: 1.19 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.23 | Chg30d=+0.004 | Revisions Net=+2 | Analysts=8
EPS next Year (2026-12-31): EPS=1.12 | Chg30d=+0.024 | Revisions Net=+4 | Growth EPS=+21.5% | Growth Revenue=-0.4%
Additional Sources for NOV Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle